These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions. Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150 [TBL] [Abstract][Full Text] [Related]
7. DNA structural distortions induced by ruthenium-arene anticancer compounds. Gossens C; Tavernelli I; Rothlisberger U J Am Chem Soc; 2008 Aug; 130(33):10921-8. PubMed ID: 18651736 [TBL] [Abstract][Full Text] [Related]
8. DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media. Kostrhunova H; Florian J; Novakova O; Peacock AF; Sadler PJ; Brabec V J Med Chem; 2008 Jun; 51(12):3635-43. PubMed ID: 18494458 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes. Tan C; Liu J; Chen L; Shi S; Ji L J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690 [TBL] [Abstract][Full Text] [Related]
11. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes. Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392 [TBL] [Abstract][Full Text] [Related]
12. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes. van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745 [TBL] [Abstract][Full Text] [Related]
13. Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. Novakova O; Kasparkova J; Bursova V; Hofr C; Vojtiskova M; Chen H; Sadler PJ; Brabec V Chem Biol; 2005 Jan; 12(1):121-9. PubMed ID: 15664521 [TBL] [Abstract][Full Text] [Related]
14. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity. Brabec V; Nováková O Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363 [TBL] [Abstract][Full Text] [Related]
15. DNA binding, cytotoxicity, and apoptotic-inducing activity of ruthenium(II) polypyridyl complex. Zhang P; Chen J; Liang Y Acta Biochim Biophys Sin (Shanghai); 2010 Jul; 42(7):440-9. PubMed ID: 20705582 [TBL] [Abstract][Full Text] [Related]
17. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells. Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404 [TBL] [Abstract][Full Text] [Related]
18. Photo-induced DNA cleavage and cytotoxicity of a ruthenium(II) arene anticancer complex. Brabec V; Pracharova J; Stepankova J; Sadler PJ; Kasparkova J J Inorg Biochem; 2016 Jul; 160():149-55. PubMed ID: 26778426 [TBL] [Abstract][Full Text] [Related]
19. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity. Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961 [TBL] [Abstract][Full Text] [Related]